LifeMD (LFMD) Preferred Stock Liabilities (2020 - 2023)

LifeMD (LFMD) has reported Preferred Stock Liabilities for 4 consecutive years, with $5.0 million the latest figure, recorded in Q2 2023.

• For the quarter ending Q2 2023, Preferred Stock Liabilities rose 16.06% year-over-year to $5.0 million; the trailing twelve-month figure through Jun 2023 stood at $5.0 million (up 16.06% YoY), and the FY2022 full-year result was $4.6 million, up 11.07% from the prior year.
• Preferred Stock Liabilities climbed to $5.0 million in Q2 2023 per LFMD's latest filing, from $4.7 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $5.0 million in Q2 2023 and bottomed at $3.7 million in Q4 2020.
• Historically, Preferred Stock Liabilities has averaged $4.2 million across 4 years, with a median of $4.2 million in 2022.
• The widest YoY moves for Preferred Stock Liabilities: up 16.06% in 2023, down 10.77% in 2023.
• Over 4 years, Preferred Stock Liabilities stood at $3.7 million in 2020, then grew by 12.45% to $4.1 million in 2021, then gained by 11.07% to $4.6 million in 2022, then advanced by 10.23% to $5.0 million in 2023.
• According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $5.0 million, $4.7 million, and $4.6 million for Q2 2023, Q1 2023, and Q4 2022 respectively.